Clovis Oncology, Inc. – CLVS: We were ahead of the company in telling you about an SEC investigation that now appears near its end. Today’s report gives a nice update on where things stand and points to a lingering concern.
To access the SEC Investigation Update, which includes our full research history on this company, click on the PDF (only visible when logged-in).
This article is premium content. To continue reading, please Sign In or Join at the top of this page.
